Trade Summary

1 week ago, Catinazzo Thomas, serving as Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 1,459 shares at $18.61 per share, for a total transaction value of $27,151.99. Following this transaction, Catinazzo Thomas now holds 158,285 shares of RLAY.

This sale represents a 0.91% decrease in Catinazzo Thomas's stake in the company.

The trade was executed on Tuesday, July 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 at 4:13 PM ET, 2 days after the trade was made.

Relay Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.